Requires private health insurers, SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover wigs under certain circumstances.
Impact
The bill aims to enhance access to necessary medical equipment for individuals facing medical hair loss due to various health conditions, including those not limited to cancer. By classifying wigs as durable medical equipment, the legislation seeks to ensure that patients receive adequate support in their recovery and rehabilitation processes. Specifically, the legislation introduces a maximum frequency of coverage for wig purchases, allowing individuals to obtain a new wig once every 36 months, thereby aligning wig coverage with other forms of medical assistance and care.
Summary
Assembly Bill A2604 proposes significant changes to health insurance policies in New Jersey by mandating coverage for wigs under specified circumstances. The bill requires private health insurers, as well as the State Health Benefits Program (SHBP), the School Employees Health Benefits Program (SEHBP), the Medicaid program, and the NJ FamilyCare program, to cover wigs in situations where a subscriber has been prescribed one by a licensed dermatologist, oncologist, or physician. This marks a shift in how medical hair loss due to illness or treatment is perceived and addressed within the healthcare system.
Contention
Notably, the bill stipulates that coverage for wigs cannot be limited to patients undergoing chemotherapy for cancer, addressing a significant gap in current insurance practices. Critics of the existing health insurance frameworks often argue that such restrictions unfairly penalize those with chronic conditions or other health issues that contribute to hair loss. By eliminating this limitation, A2604 not only broadens the scope of coverage but also fundamentally shifts the dialogue around patient rights concerning health-related necessities.
Current status
While shop programs like SHBP and SEHBP already provide some wig coverage, the bill seeks to expand these benefits uniformly across all health insurers in New Jersey. Importantly, the implementation of these provisions is contingent upon federal approval for necessary waivers under the federal Medicaid program, which indicates a level of bureaucracy that could impact the speed of its roll-out and eventual effectiveness.